The real-time pcr, digital pcr and end-point pcr global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Real-Time PCR, Digital PCR And End-Point PCR Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The real-time pcr, digital pcr and end-point pcr market size has grown strongly in recent years. It will grow from $35.11 billion in 2023 to $38.37 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to standardization of pcr protocols, role in personalized medicine, contribution to drug discovery and development, adoption in forensic and paternity testing..
The real-time pcr, digital pcr and end-point pcr market size is expected to see strong growth in the next few years. It will grow to $54.95 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expansion of molecular diagnostics, growth in infectious disease testing, increasing demand for genetic testing, market penetration in research and forensics, rapid point-of-care pcr solutions.. Major trends in the forecast period include emergence of digital assays, multiplex pcr advancements, shift towards digital pcr technology, automation and high-throughput systems, miniaturization of pcr platforms..
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report
Scope Of Real-Time PCR, Digital PCR And End-Point PCR Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Real-Time PCR, Digital PCR And End-Point PCR Market Overview
Market Drivers –
The increase in the incidence of infectious diseases is expected to propel the growth of the real-time PCR, digital PCR, and end-point PCR markets going forward. Infectious diseases refer to illnesses caused by the invasion and multiplication of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. Real-time PCR, digital PCR, and end-point PCR are utilized in infectious diseases to quantify specific pathogens or their genetic material, monitor disease progression, and rapidly diagnose infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, in July 2023, according to UNAIDS, the Switzerland-based UN program dedicated to addressing the global HIV/AIDS epidemic, the global population living with HIV increased to 39 million in 2022, up 3.17% from 37.7 million in 2020. Moreover, there were approximately 1.3 million new HIV infections reported in 2022. Furthermore, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Therefore, the increase in the incidence of infectious diseases will drive the growth of the cephalosporin market.
Market Trends –
Major companies operating in the real-time PCR, digital PCR, and end-point PCR markets are developing innovative products using advanced technologies such as digital polymerase chain reaction (dPCR) technology to better understand the nature of a patient’s cancer, genetic disease, or infection. Digital polymerase chain reaction (dPCR) technology is a biotechnological refinement of conventional polymerase chain reaction (PCR) methods that can directly quantify and clonally amplify nucleic acid strands, including DNA, cDNA, or RNA. For instance, in August 2022, Roche Diagnostics, a US-based manufacturer of medicines and medical devices, launched the next-generation digital PCR Digital LightCycler System for early detection and treatment of various chronic and genetic disorders. The system is designed to automate workflow and manage data, eliminating the need for external calculations, software, and processors. A combination of three nano well plate configurations, six advanced optical channels, and 5x concentrated DNA and RNA master mixes provides high sensitivity and precision. The Digital LightCycler System is a valuable addition to Roche’s portfolio of diagnostic platforms, providing advanced technology, clinical applications, customization and flexibility, and workflow automation.
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented –
1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations
Get an inside scoop of the real-time pcr, digital pcr and end-point pcr market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp
Regional Insights –
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time pcr, digital pcr and end-point pcr market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the real-time pcr, digital pcr and end-point pcr market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc. , Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG , Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.
Table of Contents
1. Executive Summary
2. Real-Time PCR, Digital PCR And End-Point PCR Market Report Structure
3. Real-Time PCR, Digital PCR And End-Point PCR Market Trends And Strategies
4. Real-Time PCR, Digital PCR And End-Point PCR Market – Macro Economic Scenario
5. Real-Time PCR, Digital PCR And End-Point PCR Market Size And Growth
…..
27. Real-Time PCR, Digital PCR And End-Point PCR Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
